The pathogenesis of influenza virus infections: the contributions of virus and host factors

https://doi.org/10.1016/j.coi.2011.07.016Get rights and content

Influenza viruses cause acute respiratory inflammation in humans and symptoms such as high fever, body aches, and fatigue. Usually these symptoms improve after several days; however, the 2009 pandemic H1N1 influenza virus [influenza A(H1N1) 2009] is more pathogenic than seasonal influenza viruses and the pathogenicity of highly pathogenic H5N1 viruses is still higher. The 1918 influenza pandemic virus caused severe pneumonia, resulting in an estimated 50 million deaths worldwide. Several virulence factors have been identified in these virus strains, but host factors are also responsible for the pathogenesis of infections caused by virulent viruses. Here, we review the contributions of both virus and host factors to the pathogenesis of these viral infections.

Highlights

► The pathogenicity of influenza A virus (IVA) depends on interactions between virus and host proteins. ► Among the viral proteins, HA is responsible for determining the target animal species, organs, and cell-types for IVA. ► The NS1 protein of IVA inhibits IFN-I production in virus-infected cells by interfering with the RIG-I signaling pathway. ► Pulmonary macrophages induce epithelial cell apoptosis, which is mediated by the TRAIL-DR6 interaction in the IVA-infected lung.

Introduction

Influenza viruses possess RNA as their genome and belong to the family Orthomyxoviridae [1]. Influenza A viruses (IAV), together with influenza B viruses, cause respiratory illness in humans. Wild aquatic birds are the natural reservoir of IAV [2]. Influenza pandemics occur when humans are introduced to IAVs with hemagglutinin (HA) to which they are immunologically naïve [3]. We have experienced four pandemics since the beginning of 20th century: Spanish influenza (H1N1) in 1918/1919, Asian influenza (H2N2) in 1957, Hong Kong influenza (H3N2) in 1968, and H1N1 influenza in 2009. Of these pandemic viruses, the 1918 virus was the most devastating, causing massive acute pulmonary hemorrhage and edema [4]. As antibiotics were not available then, secondary bacterial pneumonia was a major cause of death among those infected with the virus [5]. Until recently, it has been difficult to precisely evaluate the pathogenicity of the 1918 virus relative to other influenza virus strains. However, in 1999, the reverse genetics of influenza virus was established, enabling us and others to generate the 1918 virus from cloned cDNAs [6]. Infection of cynomolgus macaques with 1918 virus generated by reverse genetics resulted in severe lung damage and high virus titers, as well as disruption of the macaques’ antiviral immune responses [7]. These studies directly demonstrated that the 1918 virus possessed sufficiently high pathogenicity to cause fatal pulmonary disease.

The genome of IAV consists of eight RNA segments, encoding HA, neuraminidase (NA), nucleoprotein (NP), M1, M2, nonstructural protein (NS) 1, NS2, polymerase acidic protein (PA), polymerase basic (PB) 1, PB1-F2, and PB2. Recently, research has focused on using reverse genetics to elucidate the role of each viral protein in the pathogenicity of influenza viruses. The range of severity of diseases caused by genetically similar IAV in humans is extremely wide, indicating that host conditions play an important role in determining the pathogenesis of IAV. Experiments with mammals such as mice, guinea pigs, ferrets, and non-human primates, are employed to analyze the involvement of host factors in IAV infections, while gene-targeted mouse models are useful for testing the function of individual host genes in vivo. The secretion of type 1 interferon is induced by viral infection and produces antiviral factors; IFNβ knockout mice are susceptible to influenza virus [8]. Therefore, type I IFN is a key molecule in the innate immune responses to infection with influenza virus and the magnitude of the type I IFN response influences the pathogenicity of the virus. Thus, the pathogenesis of influenza virus infection in humans depends on a combination of virus and host factors.

Section snippets

Virulence factors

The influenza viral proteins play a role in the lung pathology of humans. Among these proteins, HA is responsible for targeting cells for infection (Table 1) [9, 10, 11]. The HA of seasonal IAV binds to α2-6 sialylated glycans, which are expressed on the surface of the epithelial cells of the upper respiratory tract in humans [12]. Because of the inflammation caused by seasonal IAV infection is mainly limited to the upper respiratory tract, the disease is mild. Nonetheless, the viruses spread

Host factors

The immune system protects the host from infection with influenza virus. Therefore, the pathogenesis of influenza virus depends on the function of the immune system. When IAV infect respiratory epithelial cells or alveolar macrophages, the single-stranded RNA of the influenza virus is recognized by toll-like receptor (TLR) 7 and retinoic acid-inducible gene-I (RIG-I) [30, 31]. The signaling pathways of TLR7 and RIG-I induce the production of type I IFNs and activate antiviral host responses [32

Summary

The pathogenicity of influenza virus is dependent on the function of viral proteins and on host immune responses, including innate and acquired immunity, indicating the importance of both viral factors and the host immune system for influenza pathogenesis. A recent report showed that commensal microflora is important for the appropriate activation of pulmonary dendritic cells to induce influenza virus-specific immune responses [61••]. Therefore, the environmental conditions that surround the

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

  • • of special interest

  • •• of outstanding interest

Acknowledgements

We thank Susan Watson for editing the manuscript. The authors were supported by the Exploratory Research for Advanced Technology (ERATO) program of the Japan Science and Technology Agency (JST), by a grant-in-aid for Specially Promoted Research from the Ministries of Education, Culture, Sport, Science, and Technology, by a grant-in-aid from Health, Labor, and Welfare of Japan, by a Contract Research Fund for the Program of Founding Research Centers for Emerging and Reemerging infectious

References (64)

  • K. Shinya et al.

    Emerging and reemerging influenza virus infections

    Vet Pathol

    (2010)
  • T. Horimoto et al.

    Influenza: lessons from past pandemics, warnings from current incidents

    Nat Rev Microbiol

    (2005)
  • J.K. Taubenberger et al.

    Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus

    Philos Trans R Soc Lond B Biol Sci

    (2001)
  • D.M. Morens et al.

    Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

    J Infect Dis

    (2008)
  • G. Neumann et al.

    Generation of influenza A viruses entirely from cloned cDNAs

    Proc Natl Acad Sci U S A

    (1999)
  • D. Kobasa et al.

    Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

    Nature

    (2007)
  • I. Koerner et al.

    Protective role of beta interferon in host defense against influenza A virus

    J Virol

    (2007)
  • E. de Wit et al.

    Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host

    J Virol

    (2010)
  • T.M. Tumpey et al.

    A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission

    Science

    (2007)
  • Y. Liu et al.

    Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus

    J Virol

    (2010)
  • K. Shinya et al.

    Avian flu: influenza virus receptors in the human airway

    Nature

    (2006)
  • S. Yamada et al.

    Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors

    Nature

    (2006)
  • G.C. Mak et al.

    Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease

    Euro Surveill

    (2010)
  • T. Horimoto et al.

    Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses

    J Virol

    (1994)
  • K.A. Bussey et al.

    PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells

    J Virol

    (2010)
  • M. Hatta et al.

    Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice

    PLoS Pathog

    (2007)
  • V.J. Munster et al.

    The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses

    J Infect Dis

    (2007)
  • Z. Li et al.

    Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model

    J Virol

    (2005)
  • M.S. Song et al.

    The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model

    J Virol

    (2009)
  • E.A. Govorkova et al.

    Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004

    J Virol

    (2005)
  • R. Salomon et al.

    The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04

    J Exp Med

    (2006)
  • T. Watanabe et al.

    Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets

    Proc Natl Acad Sci U S A

    (2009)
  • Cited by (214)

    View all citing articles on Scopus
    View full text